Electronic Warning Systems in Diagnosis and Treatment of AKI
NCT ID: NCT03119480
Last Updated: 2018-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2017-10-15
2018-10-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To Observe the method after implementing the treatment efficacy of AKI and the differences between the traditional treatment process.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients
NCT03736304
Electronic Alert for Acute Kidney Injury in Geriatric Wards
NCT04464031
Clinical Values of Automated Electronic Alert for Acute Kidney Injury
NCT02793167
Optimizing Electronic Alerts for Acute Kidney Injury
NCT02753751
Etiology, Epidemiology and Prognostics of Acute Kidney Injury (AKI)
NCT00953992
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To Observe the method after implementing the treatment efficacy of AKI and the differences between the traditional treatment process.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospital-acquired AKI
Adult patients with Hospital-acquired AKI
electronic alerts
electronic alerts for AKI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electronic alerts
electronic alerts for AKI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ding Feng
Kidney internal medicine professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feng Ding, PhD
Role: STUDY_DIRECTOR
Division of Nephrology,Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Ninth People's Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AKI-2017-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.